Introduction
============

The occurrence of infections due to pathogenic fungi has been gradually growing as assessed to occur in more than a billion humans every year worldwide ([@B36]). Diseases caused by pathogenic *Candida* spp. and other fungi continue to embody a noteworthy health burden, especially to human beings. The *Candida* species represent second most numerous agents causing fungal infection worldwide ([@B9]). Here some *Candida* spp. is highly resistant to various clinically used azoles and polyenes drugs. Moreover, *Candida* species is the fouth most common source of hospital-acquired systemic fungal infections with more than 50% mortality rates ([@B26]). It is extensively believed that more than 70% of all the fungal infections in humans are caused by the *Candida* species viz. *Candida albicans*, *Candida tropicalis*, *Candida glabrata*, and *Candida parapsilosis* ([@B26]). Investigation on the development of novel antifungal agents over the past few decades has resulted in only a few drugs, which are being clinically used ([@B7]). Five major groups of compounds are used to treat various the fungal infections and this includes azoles, polyenes, fluoropyrimidines, echinocandins, and allylamines ([@B7]). But, most of the compounds used to treat pathogenic fungi are usually synthetic in nature. But a few drugs to treat fungal infections like polyenes and echinocandins are purely natural compounds, which isolated from microbial sources. Fluconazole which comes under azole family, is the backbone in treating various infections caused by *Candida* species due to the great efficacy, reduced toxicity and inexpensive ([@B39]). However, with the widespread usage of fluconazole, the occurrence of drug resistance to many other azole derivatives emerged ([@B39]). Moreover, prolonged use of antifungals other than fluconazole in treating infections caused by *Candida* species has led to the emergence of resistance to almost all drugs used clinically. This leads to drug resistance in clinical isolates of *Candida* species mostly resulted through cross-resistance to many other drugs, a phenomenon termed as multidrug resistance (MDR). MDR is a serious problem during the treatment of opportunistic fungal infections which poses severe concern given the limited number of clinically useful antifungal drugs available in the market. Despite the accessibility of various other classes of antifungals, inherent toxicity, and development of multi drug resistance continue major problems in managing various deadly pathogenic fungi and the availability of novel antifungal drugs to over comes these situations are still limited ([@B48]). These problems point to an urgent and unmet need for the development of novel antifungal agents or searching for new antifungals from natural sources to fight against deadly fungal diseases.

*Candida* spp. are normal commensal microbes of humans, commonly found in the oral, gastrointestinal, urinary, and vaginal mucosa ([@B3]), and also produces superficial and severe systemic infections. Due to this, *Candida* spp. are also known as opportunistic fungal pathogens. *Candida* genus is most commonly recovered from hospital fungal infections and is known as candidaemia ([@B3]). *Candida* spp. are present in approximately 50% of human population and around 80% of women have suffered from *Candida* infections, with around 5% of these infections are recurring ([@B21]). Through a failure of human defense systems, *Candida* can cause severe infections in almost any part of the body, including skin, nails, urogenital, or can be systemic ([@B56]).

Wide spread used of various immunosuppressive drugs, the use of broad-spectrum antibiotics to treat various infections are responsible for an increasing number of immunocompromised peoples and this intern leads to various opportunistic infections worldwide. A debilitated or reduced immune system offers favorable situations for infectious diseases caused by various pathogenic microorganisms. AIDS due to HIV (human immunodeficiency virus) is one of the main causative features for the rising figure of peoples with various deadly fungal infections, especially by *Candida* spp. ([@B45]; [@B34]). The widespread use of antifungal drugs for prophylaxis in AIDS patients became one of the foremost reason of establishment of pathogenic *Candida*-non-*albicans* species (CNA) and increased resistance to various antifungals ([@B34]). Surprisingly, in India, *C. tropicalis*, an important CNA, is one of the major cause of severe nosocomial candidaemia in many patients ([@B34]).

Medicinal plants are well-known natural sources for the treatment of various diseases since ancient times ([@B51]). Lichens are among the most mesmerizing organisms on our planet. Lichens are a well-known, self-supporting, mutualistic association between fungi (mycobiont) and algae (photobionts) which form a unique symbiotic structure, known as lichen thallus ([@B52]). Lichen can adapt to grow in many adverse environmental conditions. Interestingly, there are no reports on the destructive microbial infections in lichens and this clearly indicated the presence of many antimicrobial compounds. The ability of lichen to produce a wide range of biologically active metabolites help to explain the fact that lichens have also been traditionally used as sources of human medicines, pigments, perfumes etc. ([@B52]). Various chemical compounds have consistently been associated with lichens, and these compounds may have pharmaceutically important properties. Interestingly, most of the lichen compounds are phenolic in nature ([@B52]).

Protolichesterinic acid (**Figure [1](#F1){ref-type="fig"}**), a higher aliphatic acid is a typical lichen compound exhibiting a wide range of pharmaceutically interesting properties. In spite of the pharmacological effects that have already been recognized, various reports have shown that protolichesterinic acid exhibits several interesting biological properties such as antimicrobial, antitumor, and antioxidant activities ([@B29]; [@B55]; [@B42]; [@B47]). All these properties were suggesting that this compound is important classes of perfect natural bioactive compound. Even though the antibacterial and anticancer properties of this compound have been explored extensively and data about the antifungal activity especially against *Candida* species lacks in the literature. The reported biological properties of protolichesterinic acid clearly highlighted the importance of this compound as leading bioactive compound with pharmacological and medical potential in the development of novel drug formulations in nearby future ([@B44]; [@B6]).

![**Chemical structure of protolichesterinic acid isolated from *U. albopunctata***. The chemical structure of protolichesterinic acid was confirmed based on the NMR and MS spectral analyses.](fphar-08-00301-g001){#F1}

Recently we have reported the purification and antimicrobial property of protolichesterinic acid from *Usnea albopunctata* ([@B35]). We also reported the preliminary anticandidal activity of protolichesterinic acid against *C. albicans* and *C. tropicalis* in the above cited paper. In the present investigation, we studied the detailed antifungal properties of protolichesterinic acid by metabolic and, morphological analyses to confirm its mechanism of action in *Candida* cells, especially *C. tropicalis*. Here, we examined both the *Candida* cell proliferation and the production of intracellular reactive oxygen species (ROS) by protolichesterinic acid as ROS play a vital role in cell death due to apoptosis. Besides, we also observed apoptotic topographies caused by protolichesterinic acid, which includes mitochondrial membrane depolarization and externalization of phosphatidylserine and calcium signals. Further, we also tested the toxicity profile of this compound against Foreskin (FS) normal fibroblast cell line. Finally, we showed protolichesterinic acid greatly prolonged the survival of *C. tropicalis* infected *C. elegans*.

Materials and Methods {#s1}
=====================

Extraction and Isolation of Protolichesterinic Acid
---------------------------------------------------

*Usnea albopunctata* were collected from Trivandrum, Kerala, India and were identified through morphological analysis and a voucher specimen has been deposited in the Crop Protection Division of CTCRI for future reference. Finely dry ground thalli of *U. albopunctata* (50 g) were extracted using acetone: methanol (1: 1) in a Soxhlet apparatus. The final extracts were filtered and then concentrated under reduced pressure in a rotary evaporator at 40°C. The dried extract was stored at -20°C for future experiments. The dried extract of the lichen *U. albopunctata* (1 g) was dissolved in ethyl acetate. After filtration, the filtrate was fractioned using silica gel column chromatography (silica gel 60, 230--400 mesh). The silica gel column was eluted with methanol-ethyl acetate solvent gradient (10: 1 and 5: 1) which yield five major fractions. The fourth fraction yielded pure protolichesterinic acid (60 mg). The chemical structure of protolichesterinic acid was confirmed based on the detailed spectral analyses (NMR and HRMS) ([@B35]).

Preparation of Protolichesterinic Acid and the Fungal Strains
-------------------------------------------------------------

A stock solution of protolichesterinic acid (50 mg/ml) dissolved in 0.5% dimethyl sulfoxide (DMSO) was used for all assays. The *Candida* strains *Candida albicans* MTCC 277, *Candida tropicalis* MTCC 230, *Candida glabrata* MTCC 3019, and *Candida parapsilosis* MTCC 6510 were used for antifungal studies. All the test fungi were obtained from MTCC (Microbial Type Culture Collection Centre), Institute of Microbial Technology (IMTECH, Chandigarh, India). The test fungi were preserved on potato dextrose agar (PDA) slants. The fungal cells were cultured in potato dextrose broth (PDB) with aeration at 37°C under agitation at 150 rpm. Initially, the fungal growth was monitored by measuring the OD at 600 nm with a microtiter ELISA plate reader. After incubation, the *Candida* cells were harvested by centrifugation at 5000 × *g* for 5 min at 4°C and washed twice in 10 ml of 0.1 M phosphate-buffered saline (PBS; pH 7). Cell pellets thus formed were resuspended in 10 ml PDB and the cell density was adjusted to 1 × 10^6^ cells/ml using a hemocytometer.

Determination of Minimum Inhibitory Concentration (MIC) of Protolichesterinic Acid
----------------------------------------------------------------------------------

Minimum inhibitory concentrations (MICs) were done by the microdilution method conferring to the reference of CLSI ([@B17]) using multi-well ELISA plates altered according to the commendations that have been mentioned for the more efficient determination of antimicrobial potential of natural compounds ([@B18]). In brief, 180 μl of PDB was dispensed aseptically to the wells of a 96-well microdilution plates. After that, 10 μl each of the serial dilutions of protolichesterinic acid and amphotericin B (AmpB) (reference antimycotic drug) were prepared in the PDB (1 to 2000 μg/ml). About 10 μl of *Candida* suspension at a density of 10^6^ CFU/ml was inoculated in each well and the plates were incubated for 48 h at 37°C. The Candidal growth was measured by taking the absorbance at 600 nm using a microtiter plate reader. Dimethyl sulfoxide and sterile water (deionized) were used as a blank control which did not inhibit the growth of *Candida* species tested. Minimum inhibitory concentration was defined as the lowest concentrations of any agent that inhibited the growth of the test microbes by ≥90% compared with that of the control. Minimum inhibitory concentrations were attained from three independent tests that performed in triplicate ([@B58]).

Minimum Fungicidal Concentration (MFC) of Protolichesterinic Acid
-----------------------------------------------------------------

To determine the minimum fungicidal concentrations (MFCs) of protolichesterinic acid and amphotericin B, an aliquot (10 μl) taken from each well that recorded total inhibition of fungal growth was plated onto PDA plates. The presence of fungal colonies was monitored after 24 h of incubation at 37°C. MFC was defined as the lowest concentration of protolichesterinic acid and amphotericin B that produced a total reduction in CFU (99.99% inhibition compared to non- treated microbial growth). The experiment was repeated for three times.

Agar DisK Diffusion Assay
-------------------------

Hundred microliter of overnight *Candida* cultures were spread over PDA plates. Six millimeter sterile filter paper disks (Hi-Media) containing MIC concentration of protolichesterinic acid and amphotericin B were placed on the agar plates. Filter paper disks incorporated with 10 μl of DMSO served as negative control. Plates were incubated at 37°C for 24 h. After incubation, the diameter of zone of inhibition was envisaged around the disks containing test substances. The antimicrobial activity of the test compounds was determined by measuring the zone of inhibition (diameter) and expressed in mm. The experiment was repeated for three times.

Cell Viability Assay
--------------------

Antifungal activity of protolichesterinic acid was tested with the colony-forming unit (CFU) assay. *Candida* species were treated with different concentrations of protolichesterinic acid (0.5× MIC, MIC, and 2× MIC) and incubated for 8 h at 37°C. About 100 μl samples from each treatment were collected at 0, 2, 4, 6, and 8 h and cells were washed with PBS and diluted serially. Dilutions were spread on PDA plates individually and incubated for 24 h at 37°C. To measure the cell viability, CFUs were counted by eye. The experiment was repeated time times.

Hyphal Induction Assay
----------------------

*Candida* hyphae were induced as reported previously ([@B60]), except *C. glabrata* (As this species does not form any hyphae). Briefly, 24 h *Candida* cells were washed thoroughly with PBS and suspended in RPMI-1640 medium comprising the protolichesterinic acid with the specified concentrations (0.5× MIC, MIC, and 2× MIC). After that, the tubes were incubated in a shaking incubator for 4 h at 37°C. The percentage of hyphal induction was calculated as the previously reported method ([@B61]).

Time-Kill Kinetic Analysis
--------------------------

Exponential-phase *Candida* cells (1 × 10^6^ cells/ml) were incubated with different concentration of protolichesterinic acid (0.5× MIC, MIC, and 2× MIC) and amphotericin B (MIC). Control cells were incubated with DMSO and sterile deionized water. About 10 μl samples from each treatment were collected at 0, 1, 2, 4, 6, 12, 24, and 48 h and serially diluted in PBS, and 50 μl aliquots were gently plated on the surface of PDA plates. The viable *Candida* colonies were counted after incubation at 37°C for 48 h. All of the experiments were performed in triplicate.

After the incubation period, the number of viable *Candida* cells was counted and expressed in log CFU/ml. The results were scrutinized and represented graphically, that is a fungal death curve vs. function of time. Data analysis for the protolichesterinic acid was measured as showing fungicidal activity when there was a decrease greater than or equal to 3 log~10~ CFU/ml of the initial inoculum, resulting in the reduction of 99.99% or more CFU/ml in 48 h compared with the initial inoculum. Fungistatic activity was considered as the decrease in growth lower than 99.99% or \<3 log~10~ in CFU/ml from the original inoculum ([@B37]).

Mechanism Action on Protolichesterinic Acid on *Candida*
--------------------------------------------------------

Out of four *Candida* species tested, *C. tropicalis* recorded the best activity and thus this strain was selected for further detailed studies including mechanism of action.

Detection of Reactive Oxygen Species (ROS) in *C. tropicalis* after Treatment with Protolichesterinic Acid
----------------------------------------------------------------------------------------------------------

5-(and-6)-chloromethyl-2′,7′-dichlorodihydrofluorescein diacetate acetyl ester (CMH~2~DCFDA) effortlessly diffuses through the microbial cell membrane, and then it is freely hydrolyzed by intracellular esterases to produce non-fluorescent dichlorofluorescein (DCFH), which is then very quickly oxidized to form extremely fluorescent 2′,7′-dichlorofluorescein (DCF) by various intracellular oxidative stressors ([@B19]). The DCF fluorescence intensity thus formed is directly proportional to the sum of intracellular ROS formed by the action of any test compounds ([@B19]). For revealing of ROS produced over a 24 h culture period, when treated with protolichesterinic acid, *C. tropicalis* was incubated with 20 μM CMH~2~DCFDA at 37°C for 2 h in the dark. Then, the *C. tropicalis* cells were collected, washed three times thoroughly with PBS buffer, resuspended in PBS, and immediately examined using a confocal microscopy (BD Pathways). The fluorescence was further measured using a spectrofluorophotometer (Shimadzu RF-5301PC, Shimadzu, Kyoto, Japan) at an excitation wavelength of 495 nm and an emission wavelength of 525 nm. 2.5 mM H~2~O~2~ was used as positive control.

*N*-Acetyl Cysteine (NAC) Assay
-------------------------------

For ROS quenching, NAC (Sigma--Aldrich, St. Louis, MO, United States) was added to the *C. tropicalis* culture (1 × 10^6^ cells/ml) to attain a final concentration of 5 mmol/L. *C. tropicalis* culture was then treated with protolichesterinic acid and amphotericin B followed by the addition of NAC. The concentrations of NAC were determined to reduce the growth inhibition of *C. tropicalis*. Colony count (CFU/ml) was monitored after 4 h exposure to the protolichesterinic acid and amphotericin B. For measuring the colony count, 100 μl of the *C. tropicalis* were collected, thoroughly washed with PBS buffer. This was then serially diluted in PBS buffer. All dilutions were plated onto PDA plates, and incubated at 37°C for 18 h. Serial dilutions that produced between 10 and 100 fungal colonies were counted, and the CFU/ml was stated as *Candida* survival (expressed in percentage) using the formula: \[(CFU/ml of *C. tropicalis* treated with test compound)/(CFU/ml of non-treated control) × 100\] ([@B26]). The results were express as mean ± standard deviation for three independent tests.

Determination of Membrane Permeabilization in *C. tropicalis*
-------------------------------------------------------------

To investigate the alteration of membrane permeabilization under protolichesterinic acid treatment, cell membrane impermeable fluorescent dye propidium iodide (PI) was used. *C. tropicalis* was treated with the concentrations of 0 (control), 0.5× MIC, MIC, and 2× MIC concentration of protolichesterinic acid in PDB with 1 × 10^6^ *Candida* cells/ml for 4 h. The amphotericin B treatment severed as the control. 2.5 mM H~2~O~2~ was used as the positive control. After incubation at 37°C for 3 h, the *Candida* cells were stained with 5 μg/ml of PI at 37°C for 30 min in the dark. The *Candida* cell membrane permeabilization was directly analyzed by confocal microscopy (BD Pathways). The fluorescence was further measured using a spectrofluorophotometer (Shimadzu RF-5301PC, Shimadzu, Kyoto, Japan) at an excitation wavelength of 535 nm and an emission wavelength of 617 nm. The test was performed trice ([@B38]).

Determination of the Release of Potassium Ions after Protolichesterinic Acid Treatment
--------------------------------------------------------------------------------------

The variation in the ion concentration due to the treatment of protolichesterinic acid was determined by the release of potassium ions. *C. tropicalis* cells (OD approximately 1) were centrifuged at 5000 rpm for 5 min and the pellet thus obtained was resuspended in 5 ml PBS and treated with the protolichesterinic acid (0.5× MIC, MIC, and 2× MIC). Amphotericin B serves as the drug control. After incubation for 5-min intervals at 37°C, the cells were centrifuged at 13,000 rpm for 10 min. The supernatant was measured using an ion-selective electrode (ISE) meter (Orion Star A214, Thermo Scientific, Singapore). The cells were sonicated to determine 100% potassium release. The percentage of potassium release caused by the compounds was calculated as follows: potassium release (%) = 100 × (\[K^+^\]-\[K^+^\]~0~)/(\[K^+^\]~t~-\[K^+^\]~0~), where \[K^+^\] represents the potassium release achieved after addition of the compounds and \[K^+^\]~0~ and \[K^+^\]~t~ represent the potassium release without the compounds and with sonication, respectively ([@B62]).

Determination of Changes in Mitochondrial Membrane Potential
------------------------------------------------------------

The fluorescent dye rhodamine 123 or RHO123 (2-\[6-amino-3-imino-3Hxanthen-9-yl\] benzoic acid methyl ester) was used to study the mitochondrial membrane potential (ΔΨm) of *C. tropicalis* after the treatment of test compound. RHO123 is a positively charged dye that usually enters any cells by diffusion. The RHO123 accumulation and retention in cells mainly depend on the ΔΨm value in response to the result of protolichesterinic acid treatment on mitochondrial transmembrane. Briefly, *C. tropicalis* (1 × 10^6^ cells/ml) in the mid-log phase were centrifuged and resuspended in PBS (pH 7.4) and incubated for 15 min at 37°C with rhodamine 123 (10 mM). The cells were again washed with PBS and treated with 0.5× MIC, MIC, and 2× MIC concentration of protolichesterinic acid for 2 h at 37°C. 2.5 mM H~2~O~2~ was used as positive control. The microscopic examination of the delivery of rhodamine 123 in the *C. tropicalis* cells was achieved through confocal laser scanning microscopy (BD Pathways). The fluorescence was further measured using a spectrofluorophotometer (Shimadzu RF-5301PC, Shimadzu, Kyoto, Japan) at an excitation wavelength of 511 nm and an emission wavelength of 534 nm. Untreated *C. tropicalis* cells were used as controls.

Detection of Phosphatidylserine Externalization through Annexin-V Staining
--------------------------------------------------------------------------

### Protoplast Preparation

The *C. tropicalis* cell wall was digested with lyticase (1 mg/g cells) in different washing steps in protoplast buffers (pH 7.4) containing 1 M sorbitol, DTT (buffer 1--30 mM; buffer 2--1 mM; buffer 3--0 mM), 50 mM tris base and 10 mM MgCl~2~. Briefly, cells were harvested and washed thrice for 5 min each with buffer 1 (3 ml/g cells). Cells were then incubated in buffer 2 (5 ml/g cells; supplemented with lyticase) for 2 h at 37°C. After removing buffer 2 by centrifugation, cells were incubated with buffer 3 (5 ml/g cells) for 15 min and then again centrifuged to remove buffer 3. Protoplasts were finally washed once with PBS and re-suspended in the same.

### Annexin-V Staining

Phosphatidylserine externalization due to apoptosis after protolichesterinic acid treatment was studied by FITC-Annexin V apoptosis detection kit (Sigma--Aldrich). For this experiment, the protoplasts were incubated with 0.5× MIC, MIC, and 2× MIC concentration of protolichesterinic acid for 2 h at 37°C and incubated for 15--20 min in an annexin binding buffer containing 5 μl of FITC-Annexin-V/ml and 5 μl of PI. After this the cells were then analyzed by confocal laser scanning microscopy. 2.5 mM H~2~O~2~ was used as positive control. The experiment was performed three times, and the results were shown as mean values ± SDs.

Studying the Cytosolic and Mitochondrial Ca^2+^ Level Up on the Treat of Protolichesterinic Acid
------------------------------------------------------------------------------------------------

To examine cytosolic and mitochondrial Ca^2+^ levels, Fura-2AM (Molecular Probes) and Rhod-2AM (Molecular Probes) were used, respectively. *C. tropicalis* cells (1 × 10^6^ cells/ml) were incubated with protolichesterinic acid (0.5× MIC, MIC, and 2× MIC) and amphotericin B at 37°C for 4 h. Ca^2+^ level was studied according to the previously reported method ([@B16]). 2.5 mM H~2~O~2~ was used as positive control.

Protolichesterinic Acid Toxicity to Leukocytes
----------------------------------------------

The toxicity of protolichesterinic acid to leukocytes was evaluated using MTT assay. Briefly, the blood was collected in a sterile heparinized tube under sterile environment. Blood was diluted with a double volume of PBS and mixed well. Using a 10 ml syringe with needle attached, 3 ml Ficoll was transferred to a clean sterile 50 ml vial. The blood was diluted on to the gradient without mixing using a sterile pipette. After this it was centrifuged for 10 min at 3000 rpm. Following centrifugation, the test tube was carefully removed and kept inside the laminar. Using a sterile Pasteur pipette, it was removed gradually and the upper layer of the solution was discarded down till within ∼1 cm of the interphase. After that, middle layer was carefully removed down till ∼0.5 cm now leaving a little material there. An equal volume of PBS was added and centrifuged for 5 min at 3000 rpm. After that the supernatant solution was removed carefully and the pellet was diluted using RPMI medium. The cells were counted using a hemocytometer. About 1 × 10^5^ cells/ml for culture was diluted and MTT experiment was performed as reported previously ([@B4]). Proliferation Rate was calculated using formula T/C × 100.

Foreskin (FS) Normal Fibroblast Cell Proliferation Inhibition Using the MTT Test
--------------------------------------------------------------------------------

### Cultivation of FS Normal Fibroblast Cell

FS cells were cultivated under standard culture conditions in minimal essential medium with Earle's salts. FS normal fibroblast growth was analyzed on the basis of the ability of living FS cells to reduce the yellow color of MTT dye (Sigma--Aldrich) to the purple formazan product. FS cells were plated in 96-well plates (3000 cells/well), and protolichesterinic acid (1--200 μg/ml) dissolved in 0.1% DMSO were added to each well, followed by incubation for 24 h under standard cultivation conditions. Afterward, the plates were centrifuged and the medium was replaced with fresh medium (150 μl) containing 0.5 mg/ml MTT. Three hours later, the MTT formazan product was dissolved in 150 μl DMSO and the absorbance was measured using an ELISA plate reader. The effects of the test compounds were quantified as the percentage of control absorbance of the reduced dye at 595 nm. Cisplatin was used as positive control. Experiments were carried out in triplicate and expressed mean ± standard deviation.

*In Vitro* Antifungal Property of Protolichesterinic Acid in *C. elegans* Infected with *C. tropicalis*
-------------------------------------------------------------------------------------------------------

*Caenorhabditis elegans -- C. tropicalis* assay was performed according to previously reported method ([@B10]). Briefly, nematodes were transferred on 48 h old *C. tropicalis* lawns \[on Brain Heart Infusion agar (BHI) plates\] for 2 h. The nematodes were washed off the plates with screen medium \[30% BHI broth in M9 buffer containing kanamycin (100 μg/ml), ampicillin (200 μg/ml), and streptomycin (200 μg/ml)\]. The screen buffer containing nematodes were re-suspended at a density of two nematodes/μl screen medium. The suspension of preinfected nematodes (20 μl) was added to wells of ELISA plates. 80 μl of screen medium containing the various concentration of protolichesterinic acid (0.5× MIC, MIC, and 2× MIC) was dispensed into the indicated well. Amphotericin B serves as the positive control. The nematodes' survival in all treatment was checked each day until 5 days ([@B11]). The nematode survival rates were calculated by counting the live and dead nematodes based on shape (live nematodes usually appear as sinusoidal while the dead nematodes appear rod shape).

Statistical Analysis
--------------------

*In vitro* susceptibility tests were repeated at least thrice on different days. All the results were presented as means ± standard deviations. Geometric means were used to compare the MIC results. Significant differences between the treatments were established using one-way ANOVA test (*P* \< 0.05).

Results
=======

Protolichesterinic Acid Recorded Strong Antifungal Effect
---------------------------------------------------------

Although previous studies conducted by various researchers on protolichesterinic acid have mainly focused on studying the preliminary antimicrobial property, there is a shortage of information on the antifungal effects especially against *Candida* species of this compound in literature. The foremost emphasis of the current investigation was to elucidate the antifungal activity and preliminary mechanism of action of protolichesterinic acid in *Candida*. Our early results clearly indicated that protolichesterinic acid has significant antifungal activity against *Candida* species, especially to *C. tropicalis* and therefore, we further conducted detailed experiments to determine its mechanism of action on *C. tropicalis*.

The results of the sensitivity test of protolichesterinic acid and the standard drug (amphotericin B) against the *Candida* species are presented in **Table [1](#T1){ref-type="table"}**. The MIC values of protolichesterinic acid ranged from 2 to 16 μg/m1, whereas the MFC values range from 4 to 32 μg/ml. But the antifungal activity of protolichesterinic acid was inferior when compared to the activity of amphotericin B (**Table [1](#T1){ref-type="table"}**). Out of four *Candida* species tested, *C. tropicalis* recorded best MIC value (2 μg/ml). Zone of inhibition obtained from agar disk diffusion experiment was presented in **Table [2](#T2){ref-type="table"}** and significant inhibition of zone was also observed for *C. tropicalis* (26 mm).

###### 

Minimum Inhibitory Concentration (MIC) of protolichesterinic acid.

  Test fungi          MIC/MFC (μg/ml)   
  ------------------- ----------------- ---------
  *C. albicans*       8/16              0.5/1
  *C. tropicalis*     2/4               1/1
  *C. glabrata*       16/32             0.5/0.5
  *C. parapsilosis*   16/32             1/1

###### 

Disk diffusion data of protolichesterinic acid.

  Test fungi          Zone of inhibition (mm)   
  ------------------- ------------------------- -----------
  *C. albicans*       21 ± 0.57                 26 ± 2.21
  *C. tropicalis*     26 ± 1.52                 27 ± 1.77
  *C. glabrata*       24 ± 1.52                 28 ± 1.12
  *C. parapsilosis*   22 ± 1                    28 ± 0.53

The antifungal activity of protolichesterinic acid was also analyzed by CFU assay. Protolichesterinic acid treated *Candida* recorded significant cell survival percentages (**Figure [2](#F2){ref-type="fig"}**). Maximum inhibition was recorded at 4 h (**Figure [2](#F2){ref-type="fig"}**). Here also *C. tropicalis* recorded significant inhibition as evidenced by low cell survival percentages.

![**Antifungal effect of protolichesterinic acid**. *Candida* species cells were treated with 0.5× MIC, MIC, and 2× MIC concentration of protolichesterinic acid and incubated for 8 h. After 0, 2, 4, 6, and 8 h the samples were collected, serially diluted, spreading in PDA agar plates and cell colonies were counted after 24 h incubation at 37°C.](fphar-08-00301-g002){#F2}

Protolichesterinic Acid Strongly Inhibits the Formation of Hyphae in *Candida* Species
--------------------------------------------------------------------------------------

Hyphal development is an important determinant for *Candida* species to effectively invade host tissues. So, we further tested the effect of the protolichesterinic acid on the inhibition of hyphal development. Excitingly, protolichesterinic acid exhibited stronger activity against the hyphal development of three *Candida* species tested (**Figure [3](#F3){ref-type="fig"}**). This result clearly indicated the high efficiency of the protolichesterinic acid against *Candida* hyphal development.

![**Inhibition of *Candidal* hyphae when treated with protolichesterinic acid**. ![](fphar-08-00301-e001.jpg) Protolichesterinic acid, ![](fphar-08-00301-e002.jpg) AmpB. Different letters in the superscript were statistically different according to Duncan's multiple range test (*p* \< 0.05).](fphar-08-00301-g003){#F3}

Time-Kill Assay
---------------

In the time-kill experiment, the outcome presented regarding the changes in the CFU/ml of viable *Candida* colonies indicated that the protolichesterinic acid exhibited potent anticandidal property (**Figure [4](#F4){ref-type="fig"}**). From the figure, it is very clear that the net growth rates sharply decreased from 2 h onward and the significant reduction in the number of *Candida* cells was recorded between 2 and 6 h when compared with untreated controls at 37°C. Interestingly, the protolichesterinic acid showed significantly better activity than amphotericin B regarding the growth of the yeast cells until 48 h incubation at 37°C. In the time-kill assay, protolichesterinic acid recorded best activity against *C. tropicalis* (**Figure [4](#F4){ref-type="fig"}**).

![**Time-kill assay of protolichesterinic acid against *Candida* species**. An overnight culture of *Candida* species were treated with 0.5× MIC, MIC, and 2× MIC of protolichesterinic acid and incubated at 37°C. Samples were collected at indicated time points and plated onto PDA plates. Plates were incubated for 48 h prior to counting the colony forming units (CFU). ![](fphar-08-00301-e003.jpg) Control, ![](fphar-08-00301-e004.jpg) AmpB, ![](fphar-08-00301-e005.jpg) 0.5× MIC, ![](fphar-08-00301-e006.jpg) MIC, ![](fphar-08-00301-e007.jpg) 2× MIC.](fphar-08-00301-g004){#F4}

In the time kill curve experiment, significant killing kinetics was recorded by 2× MIC concentrations, followed by MIC and 0.5× MIC concentration of protolichesterinic acid. Interestingly regrowth was not recorded for protolichesterinic acid.

Mechanism of Action of Protolichesterinic Acid on *C. tropicalis*
-----------------------------------------------------------------

Out of four *Candida* species tested, *C. tropicalis* recorded the best activity in the preliminary experiments and thus this strain was selected for further detailed studies including mechanism of action.

Protolichesterinic Acid Increases Total Intracellular ROS Levels in *C. tropicalis*
-----------------------------------------------------------------------------------

*Candida tropicalis* treated with protolichesterinic acid exhibited elevated ROS levels compared with untreated *C. tropicalis*. In the H~2~O~2~ (positive control) treated *C. tropicalis*, there was a significant increase in fluorescence. As shown in **Figures [5A,B](#F5){ref-type="fig"}**, cells exposed to protolichesterinic acid showed a significant raise in the intracellular ROS level when compared to untreated control *C. tropicalis* cells. Our results clearly showed that accumulation of ROS induced by protolichesterinic acid was increased in a dose-dependent manner (**Figures [5A,B](#F5){ref-type="fig"}**).

![**Intracellular ROS accumulation in *C. tropicalis* cell when treated with protolichesterinic acid**. Protolichesterinic acid increased ROS accumulation in a dose-dependent manner. Protolichesterinic acid treated *C. tropicalis* cells were incubated with H~2~DCFDA dye for 2 h at 37°C. The stained cells were measured using confocal microscope and spectrofluorophotometer. **(A)** Confocal image of *C. tropicalis*. **(B)** Fluorescence intensity of various treatments measured by spectrofluorophotometer. **(C)** The viability of cell was checked by counting (expresses as CFU/ml) after incubation with the test compound for 4 h and presented as the "percentage of cell survivals." The result represents the mean ± standard deviation from three independent assays. Different letters in the superscript were significantly different according to Duncan's multiple range test (*p* \< 0.05). Where PA is protolichesterinic acid.](fphar-08-00301-g005){#F5}

In addition, changes in *C. tropicalis* viability after adding the ROS scavenger NAC were also studied. NAC (5 mM) did not record any adverse result on *C. tropicalis*. NAC enhances the survival of the *C. tropicalis* from 46.3 to 84.25% for protolichesterinic acid (**Figure [5C](#F5){ref-type="fig"}**).

Loss of Membrane Integrity by Protolichesterinic Acid as Evidenced by Propidium Iodide Staining
-----------------------------------------------------------------------------------------------

Propidium iodide has been reported to be a useful fluorescent dye for staining membrane impermeable nucleic acid. Propidium iodide enters the cells with compromised permeability only, and then it binds tightly to the double stranded DNA. After binding it produces a significant red fluorescence when excited at 480 nm. We examined the propidium iodide uptake by *Candida* cells in the presence of the protolichesterinic acid at 0.5×, 1×, and 2× MIC by confocal microscopy (**Figure [6](#F6){ref-type="fig"}**). Here protolichesterinic acid disrupted the membrane of *C. tropicalis* as evidenced by the staining of propidium iodide. As shown in **Figure [6](#F6){ref-type="fig"}**, cells treated with protolichesterinic acid displayed an increase of red fluorescence level when compared to that of untreated cells. This result indicated that the fungal cell membrane was damaged by the treatment of protolichesterinic acid.

![**Protolichesterinic acid leads to the membrane permeabilization as evidenced propidium iodide (PI) uptake**. **(A)** Confocal image of *C. tropicalis*. **(B)** Fluorescence intensity of various treatments measured by spectrofluorophotometer. The data represent the average, standard deviation (SD), and different letters in the superscript were statistically different according to DMRT (*p* \< 0.05) test analyzed by SPSS 17.](fphar-08-00301-g006){#F6}

Efflux of Potassium Ions
------------------------

**Figure [7](#F7){ref-type="fig"}** clearly showed that the concentration of potassium ion outside of the *C. tropicalis* cell was significantly enhanced after protolichesterinic acid treatment. Usually the concentration of potassium ions within the cell is high and for maintaining the cell homeostasis it must remain as such when there are no changes in the surroundings. If any changes like cell membrane damage happen to the cells, the ions levels in the surroundings get increased. *C. tropicalis* treated with protolichesterinic acid and amphotericin B for 25 min recorded excellent potassium ions release when compared to non-treated cells. Based on the results, we confirmed that protolichesterinic acid affects *C. tropicalis* cells by destructing the cell membrane, which intern cause the permeabilization of cell membrane, and leads to the increased concentration of potassium ion outside the cells.

![**The percentage of potassium released from *C. tropicalis* induced by the compounds was measured every 5 min up to 25 min**. The results are expressed as mean ± standard deviation from three independent experiments, performed in triplicate.](fphar-08-00301-g007){#F7}

Protolichesterinic Acid Induces Collapse of Mitochondrial Membrane Potential (ΔΨm) in *C. tropicalis*
-----------------------------------------------------------------------------------------------------

To further conclude whether the mitochondria-mediated pathway is associated with protolichesterinic acid induced apoptosis in *C. tropicalis*, we studied the changes of ΔΨm by using the membrane sensitive florescence dye rhodamine 123 (Rho 123) that usually aggregates in mitochondria and produces an intense green fluorescence. The depolarization of mitochondrial membrane was significantly visible after treatment with H~2~O~2~ (which was used as the positive control). In agreement with this, protolichesterinic acid disrupted the ΔΨm as evidenced by an increase in the intensity of green fluorescence by Rho 123 (**Figure [8](#F8){ref-type="fig"}**). Moreover our results clearly showed that protolichesterinic acid enhances the intensity of fluorescent *C. tropicalis* cells in a dose-dependent manner. Therefore, protolichesterinic acid treated *C. tropicalis* were injured in permeability of mitochondria by the collapse of ΔΨm, which is a significant step in *C. tropicalis* cells undergoing programmed cell death (apoptosis).

![**protolichesterinic acid induces mitochondrial membrane depolarization (ΔΨm) of *C. tropicalis***. **(A)** Confocal image of *C. tropicalis*. **(B)** Fluorescence intensity of various treatments measured by spectrofluorophotometer. The data represent the average, SD, and different letters in the superscript were statistically different according to DMRT (*p* \< 0.05) test analyzed by SPSS 17.](fphar-08-00301-g008){#F8}

Phosphatidylserine Externalization by Protolichesterinic Acid in *Candida*
--------------------------------------------------------------------------

To differentiate between apoptotic and necrotic *Candida* cell death induced by protolichesterinic acid, Annexin V double staining assay using the FITC Annexin V and PI was selected. As revealed in **Figure [9](#F9){ref-type="fig"}**, *C. tropicalis* exposed to protolichesterinic acid were considerably stained green fluorescence (positive FITC-Annexin V and negative PI) at the edge of the cell after digestion of the cell wall, representing a very clear externalization of phosphatidylserine. FITC-Annexin V stained *C. tropicalis* cells were not recorded in experiments conducted without protolichesterinic acid (control set). The exposure phosphatidylserine from the inner to the outer leaflet of plasma membrane in cells is an early morphological marker of apoptosis. Therefore, these results suggest that protolichesterinic acid induced early apoptosis in *C. tropicalis* cells, as shown by a significant staining in Annexin V-positive apoptotic cells. From our results, we established that protolichesterinic acid induces the production and accumulation of intracellular ROS, and which finally induces apoptotic features in *C. tropicalis*.

![**Phosphatidylserine externalization showed by FITC-Annexin-V/PI staining in protolichesterinic acid-treated *C. tropicalis.*** Phosphatidylserine externalization, which is observed at an early stage of apoptosis, shown by Annexin V staining. The probe enabled the detection of alteration of phosphatidylserine localization from the inner membrane to the outer membrane. The fluorescence intensity indicates the amount of exposed phosphatidylserine in cells treated with protolichesterinic acid at the 0.5× MIC, MIC, and 2× MIC. **(A)** Confocal image of *C. tropicalis*. **(B)** Percentage of Annexin-V positive cells. The data represent the average, SD, and different letters in the superscript were statistically different according to DMRT (*p* \< 0.05) test analyzed by SPSS 17.](fphar-08-00301-g009){#F9}

Influence on the Cytoplasmic Free Ca^2+^ Concentration
------------------------------------------------------

Intracellular calcium levels were evaluated using two membrane-permeable derivatives of the ratio metric calcium indicator, Fura-2AM and Rhod-2AM to detect whether calcium signaling was involved in cell death. The concentration of cytoplasmic free Ca^2+^ in *C. tropicalis* cells treated protolichesterinic acid was higher than those in the control cells. The fluorescence intensity of Rhod-2AM was increased in cells treated with protolichesterinic acid (**Figure [10A](#F10){ref-type="fig"}**). Free calcium levels were also increased in the mitochondria of cells treated with protolichesterinic acid (**Figure [10B](#F10){ref-type="fig"}**), indicating that calcium signaling was involved in fungal cell death.

![***Candida tropicalis* cells suspensions are treated with Protolichesterinic acid alters the fluorescence intensity of Fura-2AM (A)** and Rhod-2AM **(B)**. Changes in the fluorescence intensity of Fura-2AM and Rhod-2AM were expressed as arbitrary fluorescence units, after the cell suspensions were treated with various concentration of protolichesterinic acid. Different letters in the superscript were statistically different according to DMRT (*p* \< 0.05) test analyzed by SPSS 17.](fphar-08-00301-g010){#F10}

Immunomodulatory Properties of Protolichesterinic Acid
------------------------------------------------------

The proliferation of lymphocyte was evaluated to assess the immunomodulatory properties of protolichesterinic acid. The proliferation of lymphocyte was slightly improved in cells treated with protolichesterinic acid when compared to that of the cells treated without test compound (control). Lymphocyte proliferation index was recorded to be 1.19 for 10 μg/ml of protolichesterinic acid in the presence of PHA (**Figure [11](#F11){ref-type="fig"}**).

![***In vitro* lymphocyte proliferative activity of protolichesterinic acid after 72 h of the incubation period**. Different letters in the superscript were statistically different according to DMRT (*p* \< 0.05) test analyzed by SPSS.](fphar-08-00301-g011){#F11}

Protolichesterinic Acid Recorded no Toxicity toward Normal Cell Line
--------------------------------------------------------------------

Interestingly protolichesterinic acid recorded no toxicity toward FS normal fibroblast when tested up to 200 μg/ml (**Figure [12](#F12){ref-type="fig"}**).

![**Cytotoxicity of protolichesterinic acid and cisplatin against normal cell line FS normal fibroblast**. A total of 3000 cells in triplicates well were treated with different concentrations of protolichesterinic acid for 24 h and subjected to 3-(4,5 dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide (MTT) assay. Relative cell viability was determined as percentage absorbance of protolichesterinic acid treated cells over untreated control well. Data represent three independent sets of experiments. The results represent mean ± standard deviation. Different letters in the superscript were statistically different according to DMRT (*p* \< 0.05) test analyzed by SPSS 17.](fphar-08-00301-g012){#F12}

The *In Vivo* Efficacy of Protolichesterinic Acid
-------------------------------------------------

*In vivo* studies with *C. elegans* establish that protolichesterinic acid provided substantial protection for the worms infected with *C. tropicalis* (**Figure [13](#F13){ref-type="fig"}**). Protolichesterinic acid (0.5× MIC, MIC, and 0.5× MIC) enhanced the survival of *C. tropicalis* infected nematodes with comparable efficacy as amphotericin B treatment (**Figure [13](#F13){ref-type="fig"}**).

![**Protolichesterinic acid confers improved nematodes' survival**. Nematodes were infected with *C. tropicalis* for 2 h and then moved to pathogen-free liquid media in the presence of PBS (control), protolichesterinic acid (0.5× MIC, MIC, and 2× MIC) or Amphotericin B (MIC concentration) (positive control). Each day the worms were monitored and the survival rate was calculated.](fphar-08-00301-g013){#F13}

Discussion
==========

As an opportunistic, deep-infective fungus, *Candida* species is an important infective microorganism for the patients mainly with immune dysfunction \[for e.g., chronic diabetes, malignant tumors, leukemia, organ transplantations, and acquired immunodeficiency syndrome (AIDS)\]. *Candida* species are a widespread opportunistic fungal pathogen of human beings. The aggressive candidiasis has a probable mortality rate of over 50%, even with the employ of various antifungal agents mainly due to increased drug resistance often termed as MDR *Candida* species. Therefore, the discovery of new successful antifungal drugs and therapies especially from natural sources is urgently needed ([@B22]). Antifungal compounds like azoles (fluconazole, ketoconazole, and clotrimazole) and polyenes (amphotericin B, nystatin, and natamycin) are frequently used to treat and control infections caused by various *Candida* species. The majority of the antifungal drugs are phenolic structure. The compounds with phenolic group show the highest anti-candidal property when compared to that of other class of compounds ([@B32]). In the current years, failure of drug treatment against various fungal infections such as candidiasis is usually rising due to drug-resistance and the poor efficacy of anticandidal drugs that are available in the market ([@B32]). Hence, there is a very urgent need to discover novel methods to enhance the efficiency of antifungal drugs with minimum resistance to drug for treating the infections caused by pathogenic *Candida* species. Toward this aim, finding novel compounds from natural sources and understanding its mechanism of actions are very much necessary to discover and develop new antifungal drugs to control various infectious diseases caused by pathogenic fungi.

The coming out of opportunistic fungal infections, especially in immunocompromised patients, highlights the necessity to expound novel therapeutic options. Most of the established antifungal drugs have been proved less effective against *Candida* species ([@B40]). Therefore, the research and development of new antifungal agents against *Candida* species are urgent needed ([@B40]). In the present investigation, we mainly focused on the antifungal property of protolichesterinic acid against four human pathogenic *Candida* species (*C. albicans*, *C. tropicalis*, *C. glabrata*, and *C. parapsilosis*). Protolichesterinic acid is an excellent therapeutic molecule that has been established to have many interesting biological activities ([@B54]). However, the effect of protolichesterinic acid against *Candida* species has not been elucidated. Therefore, in the present investigation, we focused on studying the antifungal property of protolichesterinic acid against *Candida* species and exploring the underlying mechanism of action. In this study, we found that protolichesterinic acid had high antifungal property against the four *Candida* species tested and out of the four *Candida* species tested, *C. tropicalis* recorded significant effect.

Lichen metabolites (depsides and depsidone) exert manifold biological activity ([@B43]; [@B42]). The structural diversity of depsides and depsidone and their occurrence in lichens have evoked substantial interest in their pharmaceutically interesting biological properties ([@B49]). Lichens have been used as the main ingredients in many folk medicines for several decades to treat various diseases as part of their traditional medicines ([@B20]). The Ayurvedic and Unani systems mentioned the medicinal properties of some lichens which are used to treat a wide array of common ailments ([@B49]). Recent studies in the field of medical have resulted in the investigation of the biological property of a limited number of lichen compounds with some investigation suggesting that certain lichen compounds possibly offer a promising new source of future drug development programs ([@B33]). More than 1000 compounds have been isolated and identified from lichens, relatively small number (∼50 species) has been screened for antibiotic activity ([@B49]).

Recent investigations have reported that pathogenic fungal infections have considerably increased ([@B46]) and natural compounds especially phytochemicals exerted significant antimicrobial effects ([@B30]). Phytochemicals have comparatively less toxicity to human beings and have a range of interesting biological properties ([@B2]). These phytochemicals are essential to a plant's reproductive system and usually prevent the entry of pathogenic microorganism which is spreading throughout the plants. Among the phytochemicals from plant, the antimicrobial property and mode of actions of certain compounds such as (+)-Medioresinol ([@B27]) and amentoflavone ([@B28]) have been well reported earlier. In this study, we reported the antifungal property of protolichesterinic acid from *U. albopunctata* and explained its mode of action against *C. tropicalis* for the first time.

Reactive oxygen species is essential for cell signaling and cell functions. Several reports have reported that the increase of ROS induces and regulates the induction of cellular apoptosis ([@B24]; [@B25]; [@B12]). As a result, to establish the intracellular ROS production and accumulation by protolichesterinic acid, we chose to employ the ROS-sensitive dye CMH~2~DCFDA, which has been used previously as a common marker for detecting the level of cellular ROS. Multiple ROS in cells directly oxidizes CMH~2~DCFDA to the very highly stable, fluorescent substance DCFDA in such a way that an enhancement in the fluorescent signal is directly proportional to the ROS production ([@B25]). Here in our study, protolichesterinic acid induces significant ROS production as evidenced by green fluorescent through confocal microscopy and spectrofluorophotometer.

Phytochemicals usually have a membrane active effect by the disturbance of the cell membrane integrity ([@B1]; [@B31]). We studied the outcome of protolichesterinic acid on the cell membrane integrity by using the fluorescence dye propidium iodide (PI). To know whether protolichesterinic acid exerts an antifungal activity by targeting the cell membrane, we investigated its effect on the integrity of cell membrane using the propidium iodide probe. Propidium iodide enters only through membrane compromised cells. After entering, PI intercalates between the guanine and the cytosine pair of DNA or with a stoichiometry of one unit dye per 3--5 base pairs. After DNA binding, the red fluorescent color of PI enhances more than 20-fold ([@B53]; [@B15]). From our study, we showed the distribution of the PI inside the *C. tropicalis* through the injured plasma membrane, and finally establish the cell membrane active mechanisms of protolichesterinic acid in *Candida* cells. Maintaining the cytoplasmic membrane integrity is essential to various important functions of microorganisms, including the formation of gradient and discriminating permeability, cellular energetic, synthesis of various biopolymers, and other key virulence determinants ([@B15]). In this admiration, any changes in the physical state of the cell membrane induced by protolichesterinic acid may hinder with one or more functions directly or indirectly. From the propidium iodide assay, we showed the diffusion of the PI into the *C. tropicalis* mainly through the injured plasma membrane. These results clearly indicated that protolichesterinic acid permeabilized the *C. tropicalis* cell membrane. To further confirm the membrane permeabilization in *Candida* cells treated with protolichesterinic acid, a potassium ion release assay was conducted. The potassium ion concentration within the cell is generally high and it must remain as such when there are no changes in the environment for maintaining the homeostasis ([@B62]). After treatment with protolichesterinic acid, the potassium ion concentration outside of the *Candida* cell was increased significantly (**Figure [7](#F7){ref-type="fig"}**). Cells treated with varying concentration of protolichesterinic acid for 25 min recorded significant release of potassium ions, as compared to untreated control cells. When any changes such as membrane damage and permeabilization occur, potassium ions are released from the cell and level of potassium ions outside the cell is directly proportional to the damaged cells. From the results, we established that protolichesterinic acid affects *C. tropicalis* by mainly destructing the cell membrane, triggering the permeabilization of the membrane, and this intern alters the potassium ion concentration inside and outside the *Candida* cells ([@B62]).

The mitochondria play an important role in the cell, for example apoptosis, pH homeostasis, redox and ATP production ([@B13]). In the mitochondria, ATP is usually formed from the phosphorylation of mitochondrial oxidative mechanism, in which ΔΨm plays a vital function ([@B13]). ΔΨm is a key factor indicating the energetic state of the cell and other cellular organelles such as mitochondria ([@B13]). Mitochondrial electron transport inhibitors, such as antimycin A and potassium cyanide, reduce ΔΨm by inhibiting the function of respiratory chain proton pumping, which leads to reduced production of ATP and this finally leads to cell death. In an earlier study presented that the antifungal activity of farnesol involves ΔΨm hyperpolarization in *C. albicans* ([@B41]). In the current study, RHO123 was used to study the effect of protolichesterinic acid on mitochondrial potentials. RHO123 is a cationic and lipophilic dye that pervades the negatively charged mitochondria and reflects ΔΨm. Exposure to different concentrations of protolichesterinic acid showed significant hyperpolarization of *C. tropicalis* ΔΨm in a dose-dependent manner, suggesting mitochondrial dysfunction. Moreover recent reports showed that mitochondria play a vital role in the induction of apoptosis; the indulgence of ΔΨm is a primary and crucial cellular event during apoptosis induced by numerous stimuli, and this disturbance leads to the opening of transition pore in mitochondrial membrane and, internally, it leads to the release of many apoptogenic factors from mitochondria into the cytosol ([@B5]).

Annexin V is a 35--36 kDa, a phospholipid binding protein with very high affinity for phosphatidylserine in the attendance of calcium ions (Ca^2+^) ([@B14]). In the present assay, *Candida* cells with apoptosis can be stained by Annexin V-FITC, which usually binds to phosphatidylserine which are externalized on the outer side of the cells, while necrotic *Candida* cells accrue only PI into the nucleus through the permeabilized plasma membrane ([@B50]). As shown in **Figure [9](#F9){ref-type="fig"}**, *Candida* exposed to protolichesterinic acid is considerably stained with green fluorescent (Annexin V-FITC: +ve, PI: -ve) at the periphery of cell after digesting the cell wall, representing clear externalization of phosphatidylserine. Annexin V-FITC stained *Candida* cells were not noticed in control experiments without protolichesterinic acid treatment. A primary morphological indicator of apoptosis is the externalization of phosphatidylserine from the inner to the outer plasma membrane in cells ([@B57]; [@B25]). This very clearly indicated that protolichesterinic acid induces cell apoptosis through mitochondrial disruption *C. tropicalis*.

Calcium signaling plays a role in the regulation of cellular processes, including the initiation and execution of apoptosis ([@B59]). Similar to mammalian cells, organelles of yeast such as the vacuoles, endoplasmic reticulum, and Golgi bodies store Ca^2+^ ions and maintenance of calcium signaling is important for normal cell survival ([@B8]). We confirmed that protolichesterinic acid induced the release of intracellular Ca^2+^ storage into the cytosol and an influx of Ca^2+^ into the mitochondria. During the apoptotic response, imbalance in the plasma membrane Ca^2+^ influx and Ca^2+^ export from the ER is known to elevate cytoplasmic calcium ion concentration, inducing a progressive increase in the mitochondrial Ca^2+^ uptake ([@B23]). This mitochondrial Ca^2+^ overload is one of the main factors that induce mitochondrial damage, mediated by perturbation or rupture due to a decrease in mitochondrial membrane potential ([@B36]). Interestingly protolichesterinic acid recorded excellent immunomodulatory property when tested against lymphocytes. Finally protolichesterinic acid showed low toxicity toward a normal human cell line FS normal fibroblast up to 200 μg/ml.

Conclusion
==========

To our knowledge, this is the first study to evaluate the physiologic mechanisms of *C. tropicalis* cell death induced by protolichesterinic acid, a depside compound. We showed that cellular apoptosis accounted for protolichesterinic acid-induced cell death through the production ROS and dysfunction of mitochondria. More over protolichesterinic acid also triggered calcium ion signaling in *C. tropicalis*. Our findings suggest that protolichesterinic acid exerts their powerful antifungal activity against *Candida* species by generating ROS, inhibiting cell wall integrity in cells, which then initiates dysfunction of mitochondria, calcium ion signaling and this internally initiate apoptosis cell death programmed (i.e., programmed cell death). This compound is also non-toxic to lymphocytes and FS normal fibroblast (normal human cell). Finally *in vivo* test showed protolichesterinic acid greatly prolonged the survival of *C. tropicalis* infected *C. elegans*.

Author Contributions
====================

All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

SK thanks, ICMR, New Delhi for providing Senior Research fellowship.

[^1]: Edited by: *Nicola Clementi, Vita-Salute San Raffaele University, Italy*

[^2]: Reviewed by: *Shamala Devisekaran, University of Malaya, Malaysia; Carlos Henrique Gomes Martins, Universidade de Franca, Brazil*

[^3]: This article was submitted to Experimental Pharmacology and Drug Discovery, a section of the journal Frontiers in Pharmacology
